| Title |
Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay
|
|---|---|
| Published in |
Journal of Interventional Cardiac Electrophysiology, April 2013
|
| DOI | 10.1007/s10840-013-9801-y |
| Pubmed ID | |
| Authors |
Kimitake Imamura, Akihiro Yoshida, Asumi Takei, Koji Fukuzawa, Kunihiko Kiuchi, Kaoru Takami, Mitsuru Takami, Mitsuaki Itoh, Ryudo Fujiwara, Atsushi Suzuki, Tomoyuki Nakanishi, Soichiro Yamashita, Akinori Matsumoto, Ken-ichi Hirata |
| Abstract |
Dabigatran is effective for both the prevention of stroke and bleeding in patients with atrial fibrillation (AF). However, the safety and efficacy of the use of dabigatran in the peri-procedural period for radiofrequency catheter ablation (RFCA) of AF is unknown. Therefore, the purpose of this study was to evaluate the safety and efficacy of dabigatran in the peri-procedural period for RFCA of AF and the duration of hospital stay. |
Mendeley readers
The data shown below were compiled from readership statistics for 117 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 1 | <1% |
| United Kingdom | 1 | <1% |
| Slovenia | 1 | <1% |
| Denmark | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 111 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 19 | 16% |
| Researcher | 17 | 15% |
| Student > Bachelor | 13 | 11% |
| Student > Ph. D. Student | 10 | 9% |
| Student > Postgraduate | 9 | 8% |
| Other | 23 | 20% |
| Unknown | 26 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 63 | 54% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 6% |
| Agricultural and Biological Sciences | 5 | 4% |
| Nursing and Health Professions | 4 | 3% |
| Computer Science | 3 | 3% |
| Other | 6 | 5% |
| Unknown | 29 | 25% |